Therapeutic strategies and emergence of multiresistant bacterial strains

Internal and Emergency Medicine

Volumn 5, Issue SUPPL. 1, 2010, Pages 45-51

  Salerno, Francesco ^a   Cazzaniga, Massimo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Albumin; Antibiotics; Ascites; Cirrhosis; Renal failure

Indexed keywords

ALBUMINOID; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES; CHRONIC KIDNEY FAILURE; DRUG EFFECT; EMPIRICISM; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MULTIDRUG RESISTANCE; PERITONITIS; RECURRENT DISEASE; RISK FACTOR; TIME;

ALBUMINS; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ASCITES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EMPIRICISM; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PERITONITIS; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 77957122895     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0447-9     Document Type: Article

References (56)

1. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJV, Planas R, Bernard B, Inadomi JM (2000) Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 32: 142-153.
2. Rajkovic IA, Williams R (1986) Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 6: 252-262.
3. Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J (1984) Reticuloendothelian system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4: 53-58.
4. Fromkes JJ, Thomas FB, Mekhjian HS, Evans M (1988) Antimicrobial activity of human ascitic fluid. Gastroenterology 73: 668-672.
5. Guarner C, Sola R, Soriano G, Andreu M, Novella MT, Vila MC, Sabat M, Coll S, Ortiz J, Gomez C, Balanzò J (1999) Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 117: 414-419.
6. Garcia-Tsao G, Wiest R (2004) Gut microflora in the pathogenesis of the complications of cirrhosis. Best Pract Res Clin Gastroenterol 18: 353-372.
7. Evans LT, Kim R, Poterucha JJ, Kamath PS (2003) Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 37: 897-901.
8. Borzio M, Salerno F, Piantoni L et al (2001) Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33: 41-48.
9. Pinzello G, Simonetti RG, Craxi A, Di Piazza S, Spano C, Pagliaro L (1983) Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients. Hepatology 3: 545-549.
10. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassul MA, Arroyo V, Rodes J (1994) Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 20: 1495-1501.
11. Runyon BA (1988) Management of adult patients with ascites caused by cirrhosis. Hepatology 27: 264-272.
12. Felisart J, Rimola A, Arroyo V, Perez-Ayuso RM, Quintero E, Gines P, Rodes J (1985) Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 5: 457-462.
13. Rimola A, Salmerón JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, Planas R, Solà R, Vargas V et al (1995) Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 21: 674-679.
14. Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA (1991) Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 100: 1737-1742.
15. Guarner C, Soriano G (1997) Spontaneous bacterial peritonitis. Semin Liver Dis 17: 203-217.
16. Salerno F, Badalamenti S (2005) Drug-induced renal failure in cirrhosis. In: Arroyo V, Ginès P, Rodés J, Schrier RW (eds) Ascites and renal dysfunction in liver disease, 2nd edn. Blackwell, MA, pp 372-382.
17. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J (2002) Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35: 140-148.
18. Ricart E, Soriano G, Novella MT, Ortiz J, Sabat M, Kolle L, Sola-Vera J, Minana J, Dedeu JM, Barrio JL, Gomez C, Guarner C (2000) Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 32: 596-602.
19. Gomez-Jimenez J, Ribera E, Gasser I, Artaza MA, Del Valle O, Pahissa A, Martinez-Vazquez JM (1993) Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients. Antimicrob Agents Chemother 37: 1587-1592.
20. Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Fornè M, Planas R et al (1996) Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 111: 1011-1017.
21. Angeli P, Guarda S, Fasolato S, Miola E, Craighero R, Del Piccolo F, Antona C, Brollo I, Franchin M, Cillo U, Merkel C, Gatta A (2006) Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. Aliment Pharmacol Ther 23: 75-84.
22. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R et al (2009) Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL). Hepatol Int 3: 269-282.
23. Thalheimer U, Triantos CK, Samonakis DN, Patch D, Burroughs AK (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54: 556-563.
24. Jalan J, Olde Damink SW, Hayes PC, Deutz NE, Lee A (2004) Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow. J Hepatol 41: 613-620.
25. Shawcross DL, Davies NA, Williams R et al (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40: 247-254.
26. Borroni GM, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F (2000) Clinical relevance of hyponatremia for the hospital outcome of cirrhotic patients. Dig Dis Sci 32: 605-610.
27. Gines P, Wong F, Watson H, Milutinovic S, del Arbol LR, Olteanu D (2008) HypoCAT study investigators effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium concentration in cirrhosis with hyponatremia a randomized trial. Hepatology 48: 204-213.
28. Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, Rimola A, Arroyo V, Rodes J (1998) Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 27: 1227-1232.
29. Sort P, Navasa M, Arroyo V, Adeguer X, Planas R, Ruiz-del-Arbol L, Castells L et al (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 403-409.
30. Cartier M, Terg R, Lucero R, Munoz A, Romero G, Levi D, Miguez C, Abecasis R (2010) Pilot study: gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis. Aliment Pharmacol Ther 32: 43-48.
31. Titò LL, Rimola A, Gines P, Llach L, Arroyo V, Rodes J (1988) Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 8: 27-31.
32. Runyon B, Squier S, Borzio M (1994) Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 21: 792-796.
33. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY (1997) Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 26: 1372-1378.
34. Shalit I (1991) Immunological aspects of new quinolones. Eur J Microbiol Infect Dis 10: 262-266.
35. Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, Forné M, Miranda ML, Llach J et al (1990) Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12: 716-724.
36. Grange JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, Blanc P et al (1998) Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol 29: 430-436.
37. Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, Vilardell F (1991) Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 100: 477-481.
38. Singh N, Gayowski T, Yu VL, Wagener MM (1995) Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med 122: 595-598.
39. Rolanchon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, Fratte S, Bohn B, Kitmacher P, Stahl JP et al (1995) Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 22: 1171-1174.
40. Bernard B, Granger J-D, Khac EN, Amiot X, Opolon P, Poynard T (1999) Antibiotic prophylaxis for the prevention of bacterial infectionsin cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29: 1655-1661.
41. Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M (2006) Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and haemorrhage. Gastroenterology 131: 1049-1056.
42. Runyon BA (1986) Low-protein concentration ascites fluid predisposed to spontaneous bacterial peritonitis. Gastroenterology 91: 1343-1346.
43. Guarner C, Sola R, Soriano G, Andreu M, Novella MT, Vila MC, Sàbat M, Coll S, Ortiz J, Gómez C, Balanzó J (1999) Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 117: 414-419.
44. Fernandez J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E et al (2007) Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133: 818-824.
45. Terg R, Fassio E, Guevara M, Cartier M, Longo C, Lucero R, Landeira C, Romero G et al (2008) Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. J Hepatol 48: 774-779.
46. Ortiz J, Vila MC, Soriano G, Minana J, Gana J, Mirelis B, Novella MT et al (1999) Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 29: 1064-1069.
47. Campillo B, Dupeyron C, Richardet JP, Mangeney N, Leluan G (1998) Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin Infect Dis 26: 1066-1070.
48. Campillo B, Dupeyron C, Richardet JP (2001) Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis. Epidemiol Infect 127: 443-450.
49. Pardo A, Bartoli R, Lorenzo Zuniga V, Planas R, Vinado B, Riba J, Cabré E, Santos J et al (2000) Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 31: 858-863.
50. Fuller R (1991) Probiotics in human medicine. Gut 32: 439-442.
51. Bauer TM, Fernandez J, Navasa M, Vila J, Rodez J (2002) Failure of Lactobacillus spp to prevent bacterial translocation in a rat model of experimental cirrhosis. J Hepatol 36: 501-506.
52. Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M, Ortiz-Berrocal J (2000) Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 31: 43-48.
53. Senzolo M, Cholongitas E, Burra P, Leandro G, Thalheimer U, Patch D, Burroughs AK (2009) Beta-blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int 29: 1189-1193.
54. Novella M, Sola R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sabat M, Vila MC, Guarner C, Vilardel F (1997) Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 25: 532-536.
55. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK (2010) Infections in patients with cirrhosis increase mortality 4-fold and should be used in determining prognosis. Gastroenterology (in press).
56. Planas R, Arroyo V (1995) Spontaneous bacterial peritonitis. Acta Gastroenterol Belg 58: 297-310.